{"product_id":"complex-ophthalmic-dosage-forms-advances-in-biomedical-applications-and-future-p-ebook","title":"Complex Ophthalmic Dosage Forms: Advances in Biomedical Applications and Future Perspectives","description":"\u003cp class=\"MsoNormal\" style=\"text-align: justify; line-height: 115%; mso-outline-level: 1;\"\u003e\u003cstrong style=\"mso-bidi-font-weight: normal;\"\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; line-height: 115%; background: white; mso-bidi-font-style: italic;\"\u003eCHAPTER 1.\u003cspan style=\"mso-spacerun: yes;\"\u003e  \u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 12.0pt; line-height: 115%; mso-ansi-language: EN-US;\"\u003eOcular drug delivery: introduction and fundamental concept.- \u003cstrong style=\"mso-bidi-font-weight: normal;\"\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003eCHAPTER 2. \u003c\/span\u003e\u003c\/strong\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003eEye: anatomy, physiology and disease.- \u003c\/span\u003e\u003c\/span\u003e\u003cstrong style=\"mso-bidi-font-weight: normal;\"\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; line-height: 115%; background: white; mso-bidi-font-style: italic;\"\u003eCHAPTER 3.\u003c\/span\u003e\u003c\/strong\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; line-height: 115%; mso-ansi-language: EN-US;\"\u003e \u003c\/span\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 12.0pt; line-height: 115%; mso-ansi-language: EN-US;\"\u003eDrug delivery to the anterior segment of eye.- \u003cstrong style=\"mso-bidi-font-weight: normal;\"\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003eCHAPTER 4\u003c\/span\u003e\u003c\/strong\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003e.\u003c\/span\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003e \u003c\/span\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003eDrug delivery to the posterior segment of eye.- \u003cstrong style=\"mso-bidi-font-weight: normal;\"\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003eCHAPTER 5\u003c\/span\u003e\u003c\/strong\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003e.\u003c\/span\u003e Fixed-dose combination approach in therapeutic delivery to the eye.- \u003cstrong style=\"mso-bidi-font-weight: normal;\"\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003eCHAPTER 6\u003c\/span\u003e\u003c\/strong\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003e.\u003c\/span\u003e Role of preservatives in ophthalmic products.- \u003cstrong style=\"mso-bidi-font-weight: normal;\"\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003eCHAPTER 7\u003c\/span\u003e\u003c\/strong\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003e.\u003c\/span\u003e Reverse engineering in complex\/combination ophthalmic product.- \u003cstrong style=\"mso-bidi-font-weight: normal;\"\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003eCHAPTER 8.\u003c\/span\u003e\u003c\/strong\u003e Role of quality by design (qbd) in ophthalmic products.- \u003cstrong style=\"mso-bidi-font-weight: normal;\"\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003eCHAPTER 9.\u003c\/span\u003e\u003c\/strong\u003e Advances and opportunities of the novel functional nanocarriers.- \u003cstrong style=\"mso-bidi-font-weight: normal;\"\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003eCHAPTER 10\u003c\/span\u003e\u003c\/strong\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003e.\u003c\/span\u003e Safety and toxicities of nanocarriers in ophthalmic drug delivery system.- \u003cstrong style=\"mso-bidi-font-weight: normal;\"\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003eCHAPTER 11.\u003c\/span\u003e\u003c\/strong\u003e Validation in sterile ophthalmic formulation.- \u003cstrong style=\"mso-bidi-font-weight: normal;\"\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; background: white; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-style: italic;\"\u003eCHAPTER 12.\u003c\/span\u003e\u003c\/strong\u003e Packaging, container and closure of ophthalmic products.- \u003cstrong\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003eCHAPTER 13\u003c\/span\u003e\u003c\/strong\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA; mso-bidi-font-weight: bold;\"\u003e. Regulatory perspectives in ophthalmic products.- \u003cstrong\u003e\u003cspan lang=\"EN-GB\" style=\"font-size: 12.0pt; font-family: 'Times New Roman',serif; mso-fareast-font-family: 'Times New Roman'; mso-ansi-language: EN-GB; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003eCHAPTER 14.\u003c\/span\u003e\u003c\/strong\u003e Polymeric microsponges for drug delivery to ocular candidiasis infections: preclinical and clinical evidences.\u003c\/span\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Neelesh Kumar Mehra","offers":[{"title":"Default Title","offer_id":53652871184711,"sku":"9789819663064","price":181.89,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0920\/5455\/2903\/files\/complex-ophthalmic-dosage-forms-advances-in-biomed-ebook-cover.webp?v=1775384059","url":"https:\/\/www.cinebuch.de\/products\/complex-ophthalmic-dosage-forms-advances-in-biomedical-applications-and-future-p-ebook","provider":"CineBuch","version":"1.0","type":"link"}